First-in-human phase I trial of the dual mTORC1 and mTORC2 inhibitor AZD2014 in solid tumors.
Udai Banerji
No relevant relationships to disclose
Emma Jane Dean
No relevant relationships to disclose
Michael Gonzalez
No relevant relationships to disclose
Alastair P Greystoke
No relevant relationships to disclose
Bristi Basu
No relevant relationships to disclose
Matthew Krebs
No relevant relationships to disclose
Martina Puglisi
No relevant relationships to disclose
Lynda Grinsted
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Elisabeth Oelmann
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Wendy Burke
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Elizabeth Harrington
Employment or Leadership Position - AstraZeneca
Stephen Green
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Malcolm Ranson
Expert Testimony - Safety Review Panel